Skip to content

Atrium Therapeutics, Inc.

RNA· Nasdaqxbrl foundCIK 2093101

Pharmaceutical preparations552 peers

Last sale
Nov 2, 2026 · +3.26%
Market cap
$184.65M
21.57M shares
Filings
61
$15.32M
Q3 2026
—
-$4.27M
Q3 2026
—
-$6.63M
Q3 2026
—
-$62.99M
Q3 2026derived
—
-$0.25
Q3 2026
—
$44.57M
Q3 2026
$184.65M
—
—
0.9×
—
—

FY2026 figures · derived

Price

$8.5688.19%$63.95since Jan 16, 2026
Nov 2, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$15.32MQ3 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Pharmaceutical preparations

Atrium Therapeutics, Inc. is the 254th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Atrium Therapeutics, Inc. · CIK 2093101 · Engraved from SEC EDGAR